Listing Details
- Listing Exchange NSE SME
- Listing Date 07-Sep-23
- IPO Price Range ₹ 26 to ₹ 28
- Listing Price ₹ 29
- Listing Change 3.6%
- Last Traded Price ₹ 32.5
- Current Change 16.1%
Mono Pharmacare IPO Details
- Open Date 28-Aug-23
- Close Date 30-Aug-23
- Lot Size 4000
- IPO Size ₹ 14.84 Cr
- IPO Price Range ₹ 26 to ₹ 28
- Min Investment ₹ 104000
- Listing Exchange NSE SME
- Basis of Allotment 04-Sep-23
- Refunds 05-Sep-23
- Credit to Demat Account 06-Sep-23
- Listing Date 07-Sep-23
Mono Pharmacare IPO Subscription Status
| Date | QIB | NII | Retail | TOTAL |
|---|---|---|---|---|
| 28-Aug-23 | 0.00 | 0.19 | 3.37 | 1.60 |
| 29-Aug-23 | 0.04 | 0.75 | 8.25 | 4.06 |
| 30-Aug-23 | 10.89 | 8.00 | 19.40 | 13.42 |
Mono Pharmacare IPO Synopsis
Mono Pharmacare Ltd. IPO is all set to open from 28th August to 30th August 2023. The company markets and distributes pharma products. The IPO includes a fresh issue of 53,00,000 shares worth ₹14.84 cr. The share allotment date is 4th September, and the IPO will be listed on 7th September on the stock exchanges. The price band is ₹26 to ₹28 per share and the lot size is 4000 shares.
Unistone Capital Private Limited is the book-running lead manager for this IPO, while Bigshare Services Private Limited is the registrar.
Objectives of Mono Pharmacare IPO:
Mono Pharmacare Limited plans to utilize the raised capital from the IPO to:
● Fulfill the working capital requirements
● For general corporate purposes
● To fund the public issue
About Mono Pharmacare
Established in 1994, Mono Pharmacare operates in the pharmaceutical industry, functioning as both a pharmaceutical product marketer and a distributor for various pharmaceutical companies. They engage with contract manufacturers to produce pharmaceutical products according to specified compositions, which are marketed under the company’s own brand, "DLS Export." Additionally, Mono Pharmacare serves as a distributor for multiple pharmaceutical companies.
As of February 2023, Mono Pharmacare has established relationships with 168 pharmaceutical companies, including distributors and stockists, while also maintaining connections with 3,036 customers and vendors. This extensive network includes a diverse mix of retail pharmacy stores and wholesalers.
The company’s product portfolio includes a wide variety of drugs, including Antibiotics, Antifungal medications, Anti-Cough and Cold remedies, Anti-allergic treatments, Antacids, Antiemetics, Analgesics and Antipyretics, Nutraceuticals, Skincare products, Antiseptics, Cardiac medications, Diabetic treatments, Cosmetics, etc.
Peer Comparison
● Chandra Bhagat Pharma Limited
For More Information:
Webstory on Mono Pharmacare IPO
Mono Pharmacare Financial Status
Profit and Loss
Balance Sheet
| Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
|---|---|---|---|
| Revenue | 58.45 | 36.98 | 28.26 |
| EBITDA | 2.97 | 1.28 | 0.85 |
| PAT | 1.23 | 0.35 | 0.095 |
| Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
|---|---|---|---|
| Total Assets | 81.09 | 14.38 | 11.22 |
| Share Capital | 12.37 | 4.30 | 4.28 |
| Total Borrowings | 63.11 | 10.10 | 7.53 |
| Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
|---|---|---|---|
| Net cash generated from / (used in) operating activities | -38.95 | 0.24 | -0.78 |
| Net cash from / (used in) investing activities | -1.22 | -0.014 | -0.064 |
| Net cash flow from / (used in) financing activities | 40.34 | -0.15 | 0.67 |
| Net increase (decrease) in cash and cash equivalents | 0.17 | 0.071 | 0.18 |
Mono Pharmacare IPO Key Points
-
Strengths
1. Experienced promoters and management.
2. Scalable business model and competitive products
3. Planning to expand product portfolio and expansion in different geographies.
-
Risks
1. Relies on the third party for product manufacturing.
2. High volume, low margin business.
3. Certain contingent liabilities can impact its business operations.
4. High working capital requirement.
5. The business is currently concentrated in Ahmedabad, Gujarat.
How to apply for IPO?
-
Login to your 5paisa account and select the issue in the
current IPO section -
Enter the number of lots and price at which you wish to
apply for -
Enter your UPI ID and click on submit. With this, your
bid will be placed with the exchange -
You will receive a mandate notification to block funds in
your UPI app -
Approve the mandate request on your UPI and funds
will be blocked
Open account in 5 minutes
Be a part of the 5paisa community now with 10 million mobile app downloads
Please keep below documents handy:
- PAN Card
- Aadhar Card
- Bank Account Number
Mono Pharmacare IPO FAQs
What is the minimum lot size and investment required for the Mono Pharmacare IPO?
The minimum lot size of Mono Pharmacare IPO is 4000 shares and the investment required is ₹1,04,000.
What is the price band of Mono Pharmacare IPO?
The price band of Mono Pharmacare IPO is ₹26 to ₹28 per share.
When does the Mono Pharmacare IPO issue open and close?
Mono Pharmacare IPO opens from 28th August to 30th August 2023.
What is the size of the Mono Pharmacare IPO issue?
The size of Mono Pharmacare IPO is ₹14.84 cr.
What is the allotment date of the Mono Pharmacare IPO?
The share allotment date of Mono Pharmacare IPO is 4th September 2023.
What is the Mono Pharmacare Ltd listing date?
The Mono Pharmacare IPO will be listed on 7th September 2023.
Who are the book runners for the Mono Pharmacare IPO?
Unistone Capital Private Limited is the book-running lead manager for Mono Pharmacare IPO.
What is the objective of Mono Pharmacare IPO?
Mono Pharmacare Ltd. plans to utilize the raised capital from the IPO to:
1. Fulfill the working capital requirements
2. For general corporate purposes
3. To fund the public issue
How to apply for the Mono Pharmacare IPO?
To apply for Mono Pharmacare IPO, follow the steps given below:
● Login to your 5paisa account and select the issue in the current IPO section
● Enter the number of lots and the price at which you wish to apply for the Mono Pharmacare Ltd. IPO.
● Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
● You will receive a mandate notification to block funds in your UPI app.
Contact Details of Mono Pharmacare IPO
Contact Information
Mono Pharmacare Limited
1A, Krinkal Apartment Opp.
Mahalaxmi Temple, Paldi
Ahmedabad -380007
Phone: +91 99780 41356
Email: cs@monopharmacareltd.com
Website: https://monopharmacareltd.com/
Mono Pharmacare IPO Register
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/ipo_status.html
Mono Pharmacare IPO Lead Manager
Unistone Capital Pvt Ltd.